Category: Allyson Small

  • ‘No going back’ for clinical trials after COVID

    Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result. The next step is ensuring the industry does not regress to old ways of working once the pandemic is over, say Karen McIntyre and Allyson Small. COVID-19 has changed everything for clinical trials – but […]